Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSTB trial of glucocorticoid induction followed by surgery in advanced thymoma with type B component
ChiCTR2300072868Phase 2Not yet recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylprednisolone and prednisone in thymoma, sponsored by Shanghai Chest Hospital. Primary endpoint: objective response rate. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
methylprednisoloneprednisone
03
Conditions
thymoma
Beyond the preview
Go deeper on ChiCTR2300072868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072868.